Does the media prefer MTD or BRKR?

In the previous week, Bruker had 6 more articles in the media than Mettler-Toledo International. MarketBeat recorded 13 mentions for Bruker and 7 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.69 beat Bruker's score of 0.38 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bruker 1 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer RGEN or MTD?

In the previous week, Mettler-Toledo International had 3 more articles in the media than Repligen. MarketBeat recorded 7 mentions for Mettler-Toledo International and 4 mentions for Repligen. Repligen's average media sentiment score of 1.38 beat Mettler-Toledo International's score of 0.69 indicating that Repligen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repligen 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MTD or TECH?

In the previous week, Bio-Techne had 4 more articles in the media than Mettler-Toledo International. MarketBeat recorded 11 mentions for Bio-Techne and 7 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.69 beat Bio-Techne's score of 0.37 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Techne 1 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to MTD or BIO?

In the previous week, Mettler-Toledo International had 3 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 7 mentions for Mettler-Toledo International and 4 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 0.69 beat Bio-Rad Laboratories' score of 0.34 indicating that Mettler-Toledo International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mettler-Toledo International 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bio-Rad Laboratories 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Mettler-Toledo International (MTD) Competitors

$1,511.60 -7.56 (-0.50%)

Closing price 09/25/2026 03:59 PM Eastern

Extended Trading

$1,514.00 +2.40 (+0.16%)

As of 09/25/2026 07:47 PM Eastern

Compare

MTD vs. BRKR, RGEN, TECH, A, and BIO

Should you buy Mettler-Toledo International stock or one of its competitors? Mettler-Toledo International's main competitors and comparable companies include Bruker (BRKR), Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), and Bio-Rad Laboratories (BIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Mettler-Toledo International compare to Bruker?

Mettler-Toledo International (NYSE:MTD) and Bruker (NASDAQ:BRKR) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.13B	7.33	$869.19M	$44.43	34.02
Bruker	$3.44B	2.85	-$8.60M	-$0.70	N/A

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by insiders. Comparatively, 27.2% of Bruker shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Bruker had 6 more articles in the media than Mettler-Toledo International. MarketBeat recorded 13 mentions for Bruker and 7 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.69 beat Bruker's score of 0.38 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bruker	1 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Mettler-Toledo International presently has a consensus price target of $1,446.36, indicating a potential downside of 4.32%. Bruker has a consensus price target of $57.00, indicating a potential downside of 11.19%. Given Mettler-Toledo International's higher possible upside, analysts plainly believe Mettler-Toledo International is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.31
Bruker	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.64

Mettler-Toledo International has a net margin of 21.91% compared to Bruker's net margin of -2.35%. Bruker's return on equity of 12.47% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.91%	-1,212.14%	25.11%
Bruker	-2.35%	12.47%	4.91%

Mettler-Toledo International has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, Bruker has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

Summary

Mettler-Toledo International beats Bruker on 10 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Repligen?

Repligen (NASDAQ:RGEN) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

In the previous week, Mettler-Toledo International had 3 more articles in the media than Repligen. MarketBeat recorded 7 mentions for Mettler-Toledo International and 4 mentions for Repligen. Repligen's average media sentiment score of 1.38 beat Mettler-Toledo International's score of 0.69 indicating that Repligen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Repligen	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.6% of Repligen shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 0.6% of Repligen shares are held by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Repligen presently has a consensus target price of $168.57, indicating a potential downside of 11.13%. Mettler-Toledo International has a consensus target price of $1,446.36, indicating a potential downside of 4.32%. Given Mettler-Toledo International's higher possible upside, analysts clearly believe Mettler-Toledo International is more favorable than Repligen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Repligen	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	3 Strong Buy rating(s)	3.00
Mettler-Toledo International	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.31

Mettler-Toledo International has higher revenue and earnings than Repligen. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Repligen	$738.26M	14.50	$48.89M	$0.73	259.84
Mettler-Toledo International	$4.13B	7.33	$869.19M	$44.43	34.02

Mettler-Toledo International has a net margin of 21.91% compared to Repligen's net margin of 5.29%. Repligen's return on equity of 5.30% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Repligen	5.29%	5.30%	3.79%
Mettler-Toledo International	21.91%	-1,212.14%	25.11%

Repligen has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

Summary

Mettler-Toledo International beats Repligen on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Techne?

Mettler-Toledo International (NYSE:MTD) and Bio-Techne (NASDAQ:TECH) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

In the previous week, Bio-Techne had 4 more articles in the media than Mettler-Toledo International. MarketBeat recorded 11 mentions for Bio-Techne and 7 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.69 beat Bio-Techne's score of 0.37 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Techne	1 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 99.0% of Bio-Techne shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by insiders. Comparatively, 1.3% of Bio-Techne shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.13B	7.33	$869.19M	$44.43	34.02
Bio-Techne	$1.22B	9.37	$181.86M	$1.15	63.14

Mettler-Toledo International currently has a consensus price target of $1,446.36, indicating a potential downside of 4.32%. Bio-Techne has a consensus price target of $68.92, indicating a potential downside of 5.08%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, research analysts clearly believe Mettler-Toledo International is more favorable than Bio-Techne.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.31
Bio-Techne	0 Sell rating(s)	15 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.12

Mettler-Toledo International has a net margin of 21.91% compared to Bio-Techne's net margin of 14.97%. Bio-Techne's return on equity of 13.23% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.91%	-1,212.14%	25.11%
Bio-Techne	14.97%	13.23%	10.61%

Mettler-Toledo International has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, Bio-Techne has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market.

Summary

Mettler-Toledo International beats Bio-Techne on 9 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Mettler-Toledo International (NYSE:MTD) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$7.37B	6.60	$1.30B	$5.08	33.98
Mettler-Toledo International	$4.13B	7.33	$869.19M	$44.43	34.02

Mettler-Toledo International has a net margin of 21.91% compared to Agilent Technologies' net margin of 19.53%. Agilent Technologies' return on equity of 24.45% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.53%	24.45%	13.09%
Mettler-Toledo International	21.91%	-1,212.14%	25.11%

87.4% of Agilent Technologies shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.2% of Agilent Technologies shares are owned by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Agilent Technologies presently has a consensus target price of $170.33, indicating a potential downside of 1.32%. Mettler-Toledo International has a consensus target price of $1,446.36, indicating a potential downside of 4.32%. Given Agilent Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe Agilent Technologies is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	5 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.80
Mettler-Toledo International	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.31

Agilent Technologies has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market. Comparatively, Mettler-Toledo International has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market.

In the previous week, Agilent Technologies had 12 more articles in the media than Mettler-Toledo International. MarketBeat recorded 19 mentions for Agilent Technologies and 7 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.69 beat Agilent Technologies' score of 0.60 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	8 Very Positive mention(s)	2 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Agilent Technologies beats Mettler-Toledo International on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Mettler-Toledo International (NYSE:MTD) and Bio-Rad Laboratories (NYSE:BIO) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.13B	7.33	$869.19M	$44.43	34.02
Bio-Rad Laboratories	$2.59B	3.93	$759.90M	$8.25	46.09

In the previous week, Mettler-Toledo International had 3 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 7 mentions for Mettler-Toledo International and 4 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 0.69 beat Bio-Rad Laboratories' score of 0.34 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bio-Rad Laboratories	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are held by institutional investors. 0.7% of Mettler-Toledo International shares are held by insiders. Comparatively, 30.3% of Bio-Rad Laboratories shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Mettler-Toledo International presently has a consensus price target of $1,446.36, indicating a potential downside of 4.32%. Bio-Rad Laboratories has a consensus price target of $343.33, indicating a potential downside of 9.71%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, equities analysts clearly believe Mettler-Toledo International is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.31
Bio-Rad Laboratories	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

Mettler-Toledo International has a net margin of 21.91% compared to Bio-Rad Laboratories' net margin of 8.59%. Bio-Rad Laboratories' return on equity of 3.54% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.91%	-1,212.14%	25.11%
Bio-Rad Laboratories	8.59%	3.54%	2.48%

Mettler-Toledo International has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, Bio-Rad Laboratories has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market.

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 13 of the 16 factors compared between the two stocks.

Get Mettler-Toledo International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTD vs. The Competition

Export

Metric	Mettler-Toledo International	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$30.29B	$10.90B	$7.33B	$22.98B
Dividend Yield	N/A	1.45%	2.52%	3.68%
P/E Ratio	34.02	73.84	275.82	28.00
Price / Sales	7.33	277.05	640.25	88.78
Price / Cash	30.45	27.55	79.52	41.27
Price / Book	-1,303.10	6.07	10.44	4.66
Net Income	$869.19M	$56.67B	$3.51B	$1.07B
7 Day Performance	8.50%	2.34%	-1.31%	-1.12%
1 Month Performance	7.42%	2.65%	-4.61%	-5.10%
1 Year Performance	25.68%	40.47%	15.01%	7.73%

Mettler-Toledo International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTD Mettler-Toledo International	2.5247 of 5 stars	$1,511.60 -0.5%	$1,446.36 -4.3%	+25.7%	$30.29B	$4.13B	34.02	18,100
BRKR Bruker	2.0429 of 5 stars	$61.58 +0.3%	$57.00 -7.4%	+106.8%	$9.35B	$3.44B	N/A	11,085
RGEN Repligen	2.633 of 5 stars	$180.71 +2.2%	$168.57 -6.7%	+51.0%	$9.98B	$738.26M	247.55	2,000	Positive News
TECH Bio-Techne	2.7868 of 5 stars	$72.47 +0.1%	$68.92 -4.9%	+40.0%	$11.35B	$1.22B	63.02	3,000	Positive News
A Agilent Technologies	4.3626 of 5 stars	$162.06 +3.6%	$170.33 +5.1%	+39.8%	$44.11B	$6.95B	31.90	18,100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MTD) was last updated on 9/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Summary

How does Mettler-Toledo International compare to Repligen?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Which has better earnings & valuation, MTD or BRKR?

Do institutionals & insiders believe in MTD or BRKR?

Does the media prefer MTD or BRKR?

Do analysts prefer MTD or BRKR?

Is MTD or BRKR more profitable?

Which has more risk & volatility, MTD or BRKR?

Summary

How does Mettler-Toledo International compare to Repligen?

Does the media prefer RGEN or MTD?

Do insiders and institutionals hold more shares of RGEN or MTD?

Do analysts rate RGEN or MTD?

Which has higher earnings and valuation, RGEN or MTD?

Is RGEN or MTD more profitable?

Which has more risk & volatility, RGEN or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Does the media prefer MTD or TECH?

Do institutionals & insiders believe in MTD or TECH?

Which has stronger valuation and earnings, MTD or TECH?

Do analysts rate MTD or TECH?

Is MTD or TECH more profitable?

Which has more risk & volatility, MTD or TECH?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Which has stronger valuation & earnings, A or MTD?

Is A or MTD more profitable?

Do institutionals and insiders have more ownership in A or MTD?

Do analysts prefer A or MTD?

Which has more volatility & risk, A or MTD?

Does the media favor A or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Which has preferable earnings and valuation, MTD or BIO?

Does the media refer more to MTD or BIO?

Do institutionals & insiders believe in MTD or BIO?

Do analysts prefer MTD or BIO?

Is MTD or BIO more profitable?

Which has more risk & volatility, MTD or BIO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools